BSE filing, NSE: MYMONEY. Summary written from the filing by ALFA Finder's alert engine.
My Money Securities Ltd: key numbers
- Share price
- ₹37.07
- Market cap
- ₹62.28 Cr
- Revenue (annual)
- ₹0.48 Cr
- Net profit (annual)
- ₹4.21 Cr
- P/E (TTM)
- 8.9×Sector 19.7×
- Promoter holding
- 63.82%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from My Money Securities Ltd
All →My Money Securities Price Movement Clarification
My Money Securities replied to a BSE surveillance query on its share price movement. The company stated there is no undisclosed price-sensitive information or promoter transaction.
My Money Securities Other Announcement
My Money Securities Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory requirements.
My Money Securities Annual General Meeting
My Money Securities held its 35th Annual General Meeting, approving financial statements, auditor/director re-appointments, and the acquisition of My Money Credits Private Limited.
My Money Securities Annual General Meeting
My Money Securities Limited submitted its Annual Report for FY 2025-26 and the Notice of the 35th Annual General Meeting scheduled for September 27, 2026.
My Money Securities Board Meeting Outcome
My Money Securities' board approved the re-appointment of Director Mr. Sanjai Seth and Statutory Auditor M/s Sharma Goel & Co. LLP, plus related party transactions.
My Money Securities Board Meeting Date
My Money Securities Limited has scheduled a Board meeting for August 27, 2026. The agenda includes auditor re-appointment, director appointments, and approval of material related party transactions.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.